229 related articles for article (PubMed ID: 25933431)
1. Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.
Bawa P; Zackaria S; Verma M; Gupta S; Srivatsan R; Chaudhary B; Srinivasan S
PLoS One; 2015; 10(5):e0122143. PubMed ID: 25933431
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.
Cui W; Qian Y; Zhou X; Lin Y; Jiang J; Chen J; Zhao Z; Shen B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S3. PubMed ID: 26100580
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis reveals enhanced regulatory effects of human long intergenic non-coding RNAs in lung adenocarcinoma.
Zhou Y; Wu K; Jiang J; Huang J; Zhang P; Zhu Y; Hu G; Lang J; Shi Y; Hu L; Huang T; Kong X
J Genet Genomics; 2015 Aug; 42(8):423-36. PubMed ID: 26336799
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling of prostate tumor and matched normal samples by RNA-Seq.
Zhai W; Yao XD; Xu YF; Peng B; Zhang HM; Liu M; Huang JH; Wang GC; Zheng JH
Eur Rev Med Pharmacol Sci; 2014; 18(9):1354-60. PubMed ID: 24867513
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Long Intergenic Noncoding RNAs: High Promoter Conservation and Dynamic, Sex-Dependent Transcriptional Regulation by Growth Hormone.
Melia T; Hao P; Yilmaz F; Waxman DJ
Mol Cell Biol; 2016 Jan; 36(1):50-69. PubMed ID: 26459762
[TBL] [Abstract][Full Text] [Related]
7. High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation.
Mills JD; Kavanagh T; Kim WS; Chen BJ; Waters PD; Halliday GM; Janitz M
Mol Brain; 2015 Jan; 8():2. PubMed ID: 25575711
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of long non-coding RNA GLIDR in prostate cancer.
Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
[TBL] [Abstract][Full Text] [Related]
9. Systematic study of human long intergenic non-coding RNAs and their impact on cancer.
Sun L; Luo H; Liao Q; Bu D; Zhao G; Liu C; Liu Y; Zhao Y
Sci China Life Sci; 2013 Apr; 56(4):324-34. PubMed ID: 23504273
[TBL] [Abstract][Full Text] [Related]
10. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
12. Prediction of regulatory long intergenic non-coding RNAs acting in trans through base-pairing interactions.
Deforges J; Reis RS; Jacquet P; Vuarambon DJ; Poirier Y
BMC Genomics; 2019 Jul; 20(1):601. PubMed ID: 31331261
[TBL] [Abstract][Full Text] [Related]
13. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites.
Idogawa M; Ohashi T; Sasaki Y; Maruyama R; Kashima L; Suzuki H; Tokino T
Hum Mol Genet; 2014 Jun; 23(11):2847-57. PubMed ID: 24403050
[TBL] [Abstract][Full Text] [Related]
14. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
[TBL] [Abstract][Full Text] [Related]
15. In silico prediction of long intergenic non-coding RNAs in sheep.
Bakhtiarizadeh MR; Hosseinpour B; Arefnezhad B; Shamabadi N; Salami SA
Genome; 2016 Apr; 59(4):263-75. PubMed ID: 27002388
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-coding RNA expression signature in human breast cancer.
Zhang Y; Wagner EK; Guo X; May I; Cai Q; Zheng W; He C; Long J
Sci Rep; 2016 Nov; 6():37821. PubMed ID: 27897201
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.
Zhang Y; Zhang P; Wan X; Su X; Kong Z; Zhai Q; Xiang X; Li L; Li Y
Biomed Pharmacother; 2016 Oct; 83():936-941. PubMed ID: 27522256
[TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.
Merry CR; McMahon S; Thompson CL; Miskimen KL; Harris LN; Khalil AM
Breast Cancer Res Treat; 2015 Apr; 150(2):321-34. PubMed ID: 25749757
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.
Ching T; Peplowska K; Huang S; Zhu X; Shen Y; Molnar J; Yu H; Tiirikainen M; Fogelgren B; Fan R; Garmire LX
EBioMedicine; 2016 May; 7():62-72. PubMed ID: 27322459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
